Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

Stress test of the skin: The cutaneous permeability barrier treadmill.

Schmuth M, Feingold KR, Elias PM.

Exp Dermatol. 2019 Nov 4. doi: 10.1111/exd.14055. [Epub ahead of print] Review.

PMID:
31682042
2.

Maximizing the benefits of cholesterol-lowering drugs.

Feingold KR.

Curr Opin Lipidol. 2019 Oct;30(5):388-394. doi: 10.1097/MOL.0000000000000631.

PMID:
31335331
3.

Going from A to Z.

Atri D, Furfaro D, Dhaliwal G, Feingold KR, Manesh R.

N Engl J Med. 2018 Jan 4;378(1):73-79. No abstract available.

PMID:
29298151
4.

Triglyceride Lowering Drugs.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Dec 4.

5.

Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines.

Hu L, Mauro TM, Dang E, Man G, Zhang J, Lee D, Wang G, Feingold KR, Elias PM, Man MQ.

J Invest Dermatol. 2017 Jun;137(6):1277-1285. doi: 10.1016/j.jid.2017.01.007. Epub 2017 Jan 20.

6.

Cholesterol Lowering Drugs.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Dec 13.

7.

Effect of inflammation on HDL structure and function.

Feingold KR, Grunfeld C.

Curr Opin Lipidol. 2016 Oct;27(5):521-30. doi: 10.1097/MOL.0000000000000333. Review.

PMID:
27495134
8.

Utility of Advanced Lipoprotein Testing in Clinical Practice.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Nov 5.

9.

Symptomatic Graves' Disease After Autoimmune Hypothyroidism.

Brondfield S, Feingold KR.

Am J Med. 2016 May;129(5):e19-20. doi: 10.1016/j.amjmed.2015.12.017. Epub 2016 Jan 6. No abstract available.

PMID:
26772649
10.

The Effect of Inflammation and Infection on Lipids and Lipoproteins.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Jan 8.

11.

Approach to the Patient with Dyslipidemia.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Jan 15.

12.

High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.

Duprez DA, Otvos J, Tracy RP, Feingold KR, Greenland P, Gross MD, Lima JA, Mackey RH, Neaton JD, Sanchez OA, Jacobs DR.

J Am Heart Assoc. 2015 Sep 14;4(9):e002295. doi: 10.1161/JAHA.115.002295.

13.

Diabetes and Dyslipidemia.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Jan 3.

14.

Introduction to Lipids and Lipoproteins.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Feb 2.

15.

Obesity and Dyslipidemia.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Apr 10.

16.

Oral and Injectable (Non-insulin) Pharmacological Agents for Type 2 Diabetes.

Feingold KR.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Jul 8.

17.

Atypical Forms of Diabetes.

Feingold KR.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Mar 19.

18.

Amiodarone Induced Thyrotoxicosis.

Macchia PE, Feingold KR.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. No abstract available.
2018 Dec 24.

19.

Kidney Stone Emergencies.

Favus MJ, Feingold KR.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. No abstract available.
2018 Sep 13.

20.

Role of Glucose and Lipids in the Cardiovascular Disease of Patients with Diabetes.

Feingold KR, Grunfeld C.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Jan 1.

21.

Thyroid Storm.

De Groot LJ, Bartalena L, Feingold KR.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. No abstract available.
2018 Dec 17.

22.

Statin myopathy: a problem looking for a solution.

Feingold KR.

Atherosclerosis. 2015 Mar;239(1):85-6. doi: 10.1016/j.atherosclerosis.2014.12.054. Epub 2015 Jan 3. No abstract available.

PMID:
25576849
23.
24.

Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.

Feingold KR, Moser A, Shigenaga JK, Grunfeld C.

J Lipid Res. 2014 Dec;55(12):2501-8. doi: 10.1194/jlr.M050955. Epub 2014 Oct 15.

25.

Paradoxical benefits of psychological stress in inflammatory dermatoses models are glucocorticoid mediated.

Lin TK, Man MQ, Santiago JL, Scharschmidt TC, Hupe M, Martin-Ezquerra G, Youm JK, Zhai Y, Trullas C, Feingold KR, Elias PM.

J Invest Dermatol. 2014 Dec;134(12):2890-2897. doi: 10.1038/jid.2014.265. Epub 2014 Jul 3.

26.

Lowered humidity produces human epidermal equivalents with enhanced barrier properties.

Sun R, Celli A, Crumrine D, Hupe M, Adame LC, Pennypacker SD, Park K, Uchida Y, Feingold KR, Elias PM, Ilic D, Mauro TM.

Tissue Eng Part C Methods. 2015 Jan;21(1):15-22. doi: 10.1089/ten.TEC.2014.0065.

27.

Basis for enhanced barrier function of pigmented skin.

Man MQ, Lin TK, Santiago JL, Celli A, Zhong L, Huang ZM, Roelandt T, Hupe M, Sundberg JP, Silva KA, Crumrine D, Martin-Ezquerra G, Trullas C, Sun R, Wakefield JS, Wei ML, Feingold KR, Mauro TM, Elias PM.

J Invest Dermatol. 2014 Sep;134(9):2399-2407. doi: 10.1038/jid.2014.187. Epub 2014 Apr 14.

28.

The adverse effect of IFN gamma on stratum corneum structure and function in psoriasis and atopic dermatitis.

Feingold KR.

J Invest Dermatol. 2014 Mar;134(3):597-600. doi: 10.1038/jid.2013.440. Erratum in: J Invest Dermatol. 2014 Nov;134(11):2851.

29.

Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis.

Elias PM, Williams ML, Choi EH, Feingold KR.

Biochim Biophys Acta. 2014 Mar;1841(3):353-61. doi: 10.1016/j.bbalip.2013.11.009. Epub 2013 Nov 27. Review.

30.

Role of lipids in the formation and maintenance of the cutaneous permeability barrier.

Feingold KR, Elias PM.

Biochim Biophys Acta. 2014 Mar;1841(3):280-94. doi: 10.1016/j.bbalip.2013.11.007. Epub 2013 Nov 18. Review.

PMID:
24262790
31.

Diabetes and risk of hospitalized fall injury among older adults.

Yau RK, Strotmeyer ES, Resnick HE, Sellmeyer DE, Feingold KR, Cauley JA, Vittinghoff E, De Rekeneire N, Harris TB, Nevitt MC, Cummings SR, Shorr RI, Schwartz AV.

Diabetes Care. 2013 Dec;36(12):3985-91. doi: 10.2337/dc13-0429. Epub 2013 Oct 15.

32.

Capsule commentary on Radin, pitfalls in hemoglobin A1c measurement: when results may be misleading.

Feingold KR.

J Gen Intern Med. 2014 Feb;29(2):363. doi: 10.1007/s11606-013-2632-9. No abstract available.

33.

Innate immunity stimulates permeability barrier homeostasis.

Feingold KR.

J Invest Dermatol. 2013 Aug;133(8):1925-7. doi: 10.1038/jid.2013.129.

34.

Ceramides stimulate caspase-14 expression in human keratinocytes.

Jiang YJ, Kim P, Uchida Y, Elias PM, Bikle DD, Grunfeld C, Feingold KR.

Exp Dermatol. 2013 Feb;22(2):113-8. doi: 10.1111/exd.12079.

35.

Lipids: a key player in the battle between the host and microorganisms.

Feingold KR, Grunfeld C.

J Lipid Res. 2012 Dec;53(12):2487-9. doi: 10.1194/jlr.E033407. Epub 2012 Oct 17. No abstract available.

36.

Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.

Lin TK, Man MQ, Santiago JL, Park K, Roelandt T, Oda Y, Hupe M, Crumrine D, Lee HJ, Gschwandtner M, Thyssen JP, Trullas C, Tschachler E, Feingold KR, Elias PM.

J Invest Dermatol. 2013 Feb;133(2):469-78. doi: 10.1038/jid.2012.335. Epub 2012 Sep 27.

37.

Tight junction properties change during epidermis development.

Celli A, Zhai Y, Jiang YJ, Crumrine D, Elias PM, Feingold KR, Mauro TM.

Exp Dermatol. 2012 Oct;21(10):798-801. doi: 10.1111/j.1600-0625.2012.01573.x. Epub 2012 Aug 7.

38.

Lamellar bodies: the key to cutaneous barrier function.

Feingold KR.

J Invest Dermatol. 2012 Aug;132(8):1951-3. doi: 10.1038/jid.2012.177.

39.

Mechanisms of triglyceride accumulation in activated macrophages.

Feingold KR, Shigenaga JK, Kazemi MR, McDonald CM, Patzek SM, Cross AS, Moser A, Grunfeld C.

J Leukoc Biol. 2012 Oct;92(4):829-39. doi: 10.1189/jlb.1111537. Epub 2012 Jun 29.

40.

Psoriasis: it's more than just the skin.

Feingold KR, Grunfeld C.

J Lipid Res. 2012 Aug;53(8):1427-9. doi: 10.1194/jlr.E029330. Epub 2012 Jun 8. No abstract available.

41.

Angiopoietin like protein 4 expression is decreased in activated macrophages.

Feingold KR, Shigenaga JK, Cross AS, Moser A, Grunfeld C.

Biochem Biophys Res Commun. 2012 May 11;421(3):612-5. doi: 10.1016/j.bbrc.2012.04.055. Epub 2012 Apr 19.

PMID:
22538368
42.

Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.

Elias PM, Williams ML, Feingold KR.

Clin Dermatol. 2012 May-Jun;30(3):311-22. doi: 10.1016/j.clindermatol.2011.08.017.

43.

Regulation of permeability barrier homeostasis.

Feingold KR, Denda M.

Clin Dermatol. 2012 May-Jun;30(3):263-8. doi: 10.1016/j.clindermatol.2011.08.008.

PMID:
22507038
44.

FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis.

Feingold KR, Grunfeld C, Heuer JG, Gupta A, Cramer M, Zhang T, Shigenaga JK, Patzek SM, Chan ZW, Moser A, Bina H, Kharitonenkov A.

Endocrinology. 2012 Jun;153(6):2689-700. doi: 10.1210/en.2011-1496. Epub 2012 Apr 2.

45.

Topical herbal extract (Huangdang mixture) exhibits both preventive and therapeutic effects in murine acute irritant contact dermatitis.

Man W, Man M, Hupe M, Martin-Ezquerra G, Feingold KR, Elias PM, Man MQ.

Int J Dermatol. 2011 Nov;50(11):1421-7. doi: 10.1111/j.1365-4632.2011.04970.x.

PMID:
22004502
46.

Inflammation inhibits GPR81 expression in adipose tissue.

Feingold KR, Moser A, Shigenaga JK, Grunfeld C.

Inflamm Res. 2011 Oct;60(10):991-5. doi: 10.1007/s00011-011-0361-2. Epub 2011 Jul 13.

PMID:
21751047
48.

The expression and regulation of enzymes mediating the biosynthesis of triglycerides and phospholipids in keratinocytes/epidermis.

Jiang YJ, Feingold KR.

Dermatoendocrinol. 2011 Apr;3(2):70-6. doi: 10.4161/derm.3.2.14995. Epub 2011 Apr 1.

49.

Lipid metabolism in the epidermis.

Feingold KR.

Dermatoendocrinol. 2011 Apr;3(2):52. doi: 10.4161/derm.3.2.15517. Epub 2011 Apr 1. No abstract available.

50.

Efficacy of combined peroxisome proliferator-activated receptor-╬▒ ligand and glucocorticoid therapy in a murine model of atopic dermatitis.

Hatano Y, Elias PM, Crumrine D, Feingold KR, Katagiri K, Fujiwara S.

J Invest Dermatol. 2011 Sep;131(9):1845-52. doi: 10.1038/jid.2011.144. Epub 2011 Jun 2.

Supplemental Content

Loading ...
Support Center